Is AGMB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, AgomAb Therapeutics NV American Depositary Shares has a Smart Value Score of 21/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

AGMB

AgomAb Therapeutics NV American Depositary Shares

NASDAQ: AGMB · HEALTHCARE · BIOTECHNOLOGY

$10.74

+0.94% today

Updated 2026-04-29

Market cap

$528.92M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.50

Dividend yield

—

52W range

$9 – $17

Volume

0.2M

Market cap

$528.92M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.50

Dividend yield

—

52W range

$9 – $17

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$32.00

+197.95%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-12.80M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	—
Net income	$-8.14M	$-11.39M	$-46.27M	$-46.27M	$-11.73M
EPS	—	—	—	—	$-1.50
Free cash flow	$-18.97M	$-24.59M	$-47.50M	$-51.74M	$-12.80M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AGMB	$528.92M	21	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

AgomAb Therapeutics NV American Depositary Shares trades at $10.74. Our Smart Value Score of 21/100 indicates the stock is weak.

Frequently asked questions

What is AgomAb Therapeutics NV American Depositary Shares's stock price?

AgomAb Therapeutics NV American Depositary Shares (AGMB) trades at $10.74.

Is AgomAb Therapeutics NV American Depositary Shares overvalued?

Smart Value Score 21/100 (Grade F, Strong Sell).

What is the price target of AgomAb Therapeutics NV American Depositary Shares (AGMB)?

The analyst target price is $32.00, representing +198.0% upside from the current price of $10.74.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-39.20%

Beta—

50D MA$12.64

200D MA$12.99

Shares out0.05B

Float0.00B

Short ratio—

Avg volume0.2M

Performance

1 week+3.38%

1 month+4.33%

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

AGMB vs LLY →AGMB vs JNJ →AGMB vs ABBV →Stock screener →